The immunometabolic role of TLR2 and TLR4 makes these receptors and their associated pathways critical for identifying targets to treat metabolic conditions such as obesity-induced inflammation and type-2 diabetes (T2D). This evidence concerns the gene TLR4 and obesity due to melanocortin 4 receptor deficiency.